Is Hyperkalemic periodic paralysis hereditary?

Hyperkalemic periodic paralysis is a hereditary condition, meaning it is passed down through families due to specific genetic mutations rather than being acquired later in life. It follows an autosomal dominant inheritance pattern, which means that an individual only needs one copy of the altered gene from one parent to potentially develop the condition.

Is Hyperkalemic periodic paralysis strictly hereditary?

Yes, Hyperkalemic periodic paralysis is a genetic disorder caused by mutations in the SCN4A gene, which provides instructions for making a sodium channel protein in skeletal muscle cells. While the condition is hereditary, it is important to distinguish between "genetic" and "hereditary." Because it is caused by a DNA mutation, it is genetic; because that mutation can be passed from parent to child, it is hereditary. In our community at DiseaseMaps.org, where 21 people with Hyperkalemic periodic paralysis have shared their experiences, many families report observing the condition across multiple generations.

What is the inheritance pattern of Hyperkalemic periodic paralysis?

Hyperkalemic periodic paralysis typically follows an autosomal dominant inheritance pattern. This means there is a 50% chance that a child of an affected parent will inherit the mutation. However, the condition exhibits "incomplete penetrance" and "variable expressivity," meaning that even if a family member inherits the gene, they may experience symptoms with varying degrees of severity, or in some cases, may show very few clinical signs at all.

Are de novo (spontaneous) mutations common?

While most cases of Hyperkalemic periodic paralysis are inherited from an affected parent, de novo mutations—where the mutation appears for the first time in an individual with no family history—do occur. These spontaneous mutations happen during the formation of reproductive cells or early in embryonic development. While they are less common than familial transmission, they are a documented cause of the condition in individuals without a clear family history.

How is genetic testing utilized for this condition?

Genetic testing is the gold standard for confirming a diagnosis of Hyperkalemic periodic paralysis. Molecular genetic testing involves analyzing the SCN4A gene to identify pathogenic variants. Clinical geneticists recommend testing when a patient presents with episodic muscle weakness and hyperkalemia (high blood potassium levels). For families, genetic counseling is highly recommended to:

• Explain the 50% recurrence risk for future children.


• Discuss the implications of genetic results for extended family members who may be asymptomatic carriers.


• Provide guidance on reproductive options, such as prenatal diagnosis or preimplantation genetic testing (PGT).


• Help families navigate the emotional impact of receiving a genetic diagnosis for Hyperkalemic periodic paralysis.

Next steps

• Consult with a clinical geneticist or a neurologist specializing in neuromuscular disorders to discuss genetic testing options.


• Connect with the 21 other members of our DiseaseMaps.org community to share experiences on managing symptoms and navigating family discussions.


• Request a referral to a genetic counselor to create a family pedigree and discuss reproductive planning.


• Review your family history to identify other relatives who may have experienced unexplained episodes of muscle weakness.

Medical disclaimer: This information is for educational purposes only and does not constitute medical advice, diagnosis, or treatment; always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition.

References

• NIH Genetic and Rare Diseases (GARD) Information Center: Hyperkalemic periodic paralysis.


• Orphanet: Hyperkalemic periodic paralysis (ORPHA:2860).


• OMIM (Online Mendelian Inheritance in Man): Periodic Paralysis, Hyperkalemic (Entry #170500).


• The Muscular Dystrophy Association (MDA): Information on Periodic Paralysis.